Cancer News - Treatment Options

New Radiotherapy Technique Shown to Be Safe for Cancer Patients

A new technique, known as stereotactic body radiotherapy (SBRT), is safe for patients with recurrent head and neck cancers, and may improve their quality of life, according to researchers.

http://hospimedica.com//?option=com_article&Itemid=294724383&cat=Critica...

Endoscopic Surgery As Effective Open Surgery For Nasal Cancer

ScienceDaily (July 7, 2009) — Researchers from Boston University School of Medicine (BUSM) have shown that endoscopic surgery is a valid treatment option for treating esthesioneuroblastoma (cancer of the nasal cavity), in addition to traditional open surgery and nonsurgical treatments.

http://www.sciencedaily.com/releases/2009/07/090707131832.htm

Voice Box Can Be Preserved, Even With The Largest Cancers, Study Suggests

ScienceDaily (June 25, 2009) — Some patients with large tumors on their larynx can preserve their speech by opting for chemotherapy and radiation over surgery to remove the voice box.

http://www.sciencedaily.com/releases/2009/06/090625133209.htm

Longer Hormone Treatment May Improve Prostate Cancer Outlook

European and U.S. studies find similar results

WEDNESDAY, June 10 (HealthDay News) -- Men with moderately advanced prostate cancer who get hormone-blocking drugs after radiation therapy do better when the drug treatment is continued for two or more years after an initial six-month regimen, a European study has found.

http://www.healthscout.com/news/1/627941/main.html

Prostate Cancer Treatment Side Effects Explored
Differences in quality of life after therapies should affect treatment choice

THURSDAY, June 11 (HealthDay News) -- The treatments for localized prostate cancer -- prostatectomy, brachytherapy, and external radiation -- have varied side effect profiles, and these should be taken into consideration in the selection of a treatment, according to a study published online June 9 in the Journal of the National Cancer Institute.

http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Prostat...

Lapatinib May Work Against Certain Inflammatory Breast Cancers

Women with HER2+ inflammatory breast cancer who haven't responded to other cancer treatments may benefit from lapatinib (Tykerb), according to results from a phase II study published this month in The Lancet Oncology.

http://www.cancer.org/docroot/NWS/content/NWS_1_1x_Lapatinib_May_Work_Ag...

'Micro' Spreading of Breast Cancer Needs Treating, Study Urges

MONDAY, June 1 (HealthDay News) -- Researchers are now recommending that doctors treat women with breast cancer who have tiny metastases in the so-called sentinel lymph nodes.

http://www.medicinenet.com/script/main/art.asp?articlekey=100859

New Treatment Combination Proves Safe For Head And Neck Cancer Patients, Study Suggests

ScienceDaily (May 30, 2009) — Patients undergoing treatment for advanced head and neck cancers may respond well to the addition of gefinitib to chemotherapy, according to a study sponsored by the Eastern Cooperative Oncology Group and chaired by Ethan Argiris, M.D., associate professor of medicine, University of Pittsburgh School of Medicine, and co-leader of the Head and Neck Cancer Program of the University of Pittsburgh Cancer Institute (UPCI).

http://www.sciencedaily.com/releases/2009/05/090531083621.htm

Delivering Chemo Directly Into Brain Tumors Shows Promise

MONDAY, May 4 (HealthDay News) -- Using a catheter to deliver chemotherapy drugs directly into a deadly type of brain tumor is showing promise in early clinical trials, researchers report.

http://www.medicinenet.com/script/main/art.asp?articlekey=99946

Genetic Research Work Opens Up New Horizons To The Design Of Customized Medicines Against Breast Cancer

ScienceDaily (May 5, 2009) — Research work carried out at the University of Granada (Spain), in collaboration with the Hospital Complex of Jaén (Services of Medical Oncology, Radiology and Pathological Anatomy), has opened up new horizons to the design of customized medicines against breast cancer, from the genetic study of cancer cells.

http://www.sciencedaily.com/releases/2009/05/090505132144.htm